Basic Stalevo Information

• INN (International Nonproprietary Name): Levodopa, Carbidopa, Entacapone.
• Brand Names Available In Canada (English): Stalevo — film-coated tablets (Novartis/Orion).
• ATC Code: N04BA03 (Levodopa combinations).
• Forms & Dosages: Film-coated tablets containing 200 mg entacapone with varying levodopa/carbidopa pairs:
  • Stalevo 50: 50 mg levodopa + 12.5 mg carbidopa + 200 mg entacapone.
  • Stalevo 75: 75 mg levodopa + 18.75 mg carbidopa + 200 mg entacapone.
  • Stalevo 100: 100 mg levodopa + 25 mg carbidopa + 200 mg entacapone.
  • Stalevo 125: 125 mg levodopa + 31.25 mg carbidopa + 200 mg entacapone.
  • Stalevo 150: 150 mg levodopa + 37.5 mg carbidopa + 200 mg entacapone.
  • Stalevo 200: 200 mg levodopa + 50 mg carbidopa + 200 mg entacapone.
• Manufacturers In Canada (English): Novartis/Orion (distributed under Novartis/Orion branding).
• Registration Status In Canada (English): Approved and marketed as prescription-only film-coated tablets.
• OTC / Rx Classification: Prescription Only Medicine (Rx).

Worried about keeping medicines safe and travel-ready in Canada?

Always follow your prescriber’s instructions and keep medications in their original packaging for identification and provincial coverage requirements.

Store Stalevo below 30°C and protect tablets from moisture and light.

Carry your prescription details and insurance information when travelling across provinces or internationally because bilingual labelling and provincial coverage rules can affect refills.

If you experience severe confusion, severe dyskinesia, chest pain, or fainting, seek urgent medical care immediately.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Do your Parkinson’s symptoms start stiff in the morning or worsen by evening?

Match Stalevo dosing to the times you need the medication to work best, and discuss symptom patterns with your prescriber.

Stalevo tablets come in graded strengths that let prescribers align morning “on” needs and evening control by matching the patient’s current levodopa/DDCI dose.

Many Canadians take the first tablet on waking with a light snack to reduce nausea and then space doses every three to four hours.

Typical dosing frequency ranges from three to seven times daily, adjusted for symptom control and tolerability.

For shift-workers or caregivers, set alarms and keep a dose log or checklist to avoid missed doses.

Taking With Or Without Meals (Canadian Diet Context)

Are protein-heavy breakfasts or big dinners changing how Stalevo works for you?

Protein-rich meals can reduce levodopa absorption, so consider having smaller protein portions at the main levodopa doses or shifting protein to later meals in consultation with your clinician.

High-fat breakfasts common in some Canadian diets may delay absorption, so test timing with your prescriber or pharmacist to see what fits your routine.

Never double doses for missed pills; take a missed dose as soon as you remember but do not take two doses at once.

Maintain a daily checklist and consider sharing a pillbox photo with a pharmacist for review when dosing questions arise.

Practical Tips

• Keep a dosing diary: note times, symptom response, and any nausea or dizziness.
• Use reminders: alarms or a checklist are especially useful for caregivers and shift-workers.
• Bring medications to appointments: tablet photos or packaging help prescribers match and adjust Stalevo dosing.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Concerned whether Stalevo is right for you?

Stalevo is prescription-only in Canada and is not suitable for people with known hypersensitivity to any component.

Do not use Stalevo if you have narrow-angle glaucoma, severe liver disease, or pheochromocytoma.

Discuss any history of psychosis, severe cardiovascular disease, severe renal impairment or active liver problems with your prescriber before starting.

Because entacapone exposure increases in hepatic impairment, dose reduction or avoidance may be necessary.

Activities To Limit (Driving, Workplace Safety)

Worried about driving or workplace risks while starting Stalevo?

Stalevo can cause dizziness, orthostatic hypotension, and sudden sleep episodes, so avoid driving, operating heavy machinery, and high‑risk jobs until you know how it affects you.

Employers or occupational health services in Canada may request documentation; provincial safety standards vary.

Keep a symptom diary and report falls, syncope, or sudden sleep attacks right away to your prescriber and pharmacist.

• Contraindications: narrow-angle glaucoma; severe liver disease; pheochromocytoma; known hypersensitivity.
• Warnings: history of psychosis; severe cardiovascular disease; use with non‑selective MAO inhibitors.
• Workplace checklist: avoid driving until effects are known; inform occupational health; document episodes of dizziness or sleepiness.

Dosage & Adjustments

General Regimen (DIN References)

Wondering how Stalevo dosing is chosen?

Stalevo tablets are available in strengths from 50/12.5/200 up to 200/50/200, with each tablet containing 200 mg entacapone and varying levodopa/carbidopa amounts.

Initiation usually matches the patient’s current levodopa/DDCI dose, with titration to the closest Stalevo tablet strength.

Maintenance commonly involves one tablet per dose taken three to seven times daily according to symptom control.

Ask your pharmacist to confirm the product’s Drug Identification Number (DIN) and expiry before accepting refills.

Special Cases (Elderly, Comorbidities)

Do you care for an older adult starting Stalevo?

Start low and go slow in older adults and monitor for orthostatic hypotension, confusion, and dyskinesia.

Use caution in renal impairment and closely monitor adverse effects.

In hepatic impairment, entacapone exposure increases; avoid or reduce dose as clinically indicated.

Stalevo is not indicated in patients under 18 years.

Tablet Strengths And Matching Guide

User Testimonials

Positive Reports From Canadian Patients

Curious what other Canadians say about Stalevo?

Many patients report improved “on” time and easier pill routines after switching from separate levodopa/DDCI plus entacapone to a single-tablet Stalevo regimen.

Positive notes often cite fewer missed entacapone doses and more consistent symptom control, particularly where urban pharmacies like Shoppers Drug Mart and Rexall provide reliable access.

Common Challenges In Forums (Reddit Canada, Health Boards)

Looking for practical tips from peers?

Canadian-reported issues include cost and coverage barriers, nausea during initiation, and day-to-day fluctuations that require fine-tuning.

Rural patients may face delays sourcing specific strengths, and users often recommend pre-authorizations for provincial plans and carrying a printed copy of the prescription when travelling between provinces.

• Tips From Patients: ask your pharmacist about provincial coverage steps; photograph pill packaging; request a medication review after switching.
• New-User Checklist: confirm tablet strength, keep a symptom diary, schedule a dosage follow-up within 1–4 weeks.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Where can Canadians get Stalevo?

Stalevo is prescription-only and available through major Canadian chains such as Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs, as well as independent pharmacies.

Ask your pharmacist to confirm generic availability, tablet strengths, and that bilingual labelling is present on packaging and leaflets.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

Trying to manage cost and access?

Prices and coverage vary by province and private plans, so check provincial formularies like Ontario Drug Benefit, BC PharmaCare, and RAMQ for potential criteria or prior authorization.

Some patients compare in-store pickup with online delivery; rural pharmacies may need 24–72 hours to source specific strengths.

Cross-border purchasing can appear cheaper but comes with customs rules and prescription verification; always confirm the DIN and legality before importing.

In our online pharmacy, stalevo is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Refill Planning Checklist

• Confirm provincial coverage and any prior authorization steps.
• Check current DIN and expiry on the bottle when refilling.
• Schedule refills early if you live in a rural area to avoid delays.

What’s Inside & How It Works

Ingredients Overview

Want a quick breakdown of the active components?

Stalevo contains three active ingredients: levodopa, carbidopa, and entacapone.

Each film-coated tablet includes a fixed 200 mg entacapone plus a levodopa/carbidopa pair tailored by strength.

Carbidopa reduces peripheral levodopa metabolism and associated nausea, while entacapone inhibits COMT to prolong levodopa’s plasma half‑life.

Mechanism Basics

How does this triple combination improve Parkinson’s symptoms?

Levodopa converts to dopamine in the brain to improve motor symptoms associated with Parkinson’s disease.

Carbidopa blocks peripheral conversion to dopamine, reducing nausea and allowing more levodopa to reach the brain.

Entacapone blocks peripheral COMT enzymes, extending levodopa’s action and reducing “wearing off” between doses compared with levodopa/carbidopa alone.

• Levodopa: dopamine precursor for central effect.
• Carbidopa: peripheral DDC inhibitor to limit nausea and peripheral breakdown.
• Entacapone: COMT inhibitor to increase and prolong levodopa plasma levels.

Main Indications

Approved Uses In Canada

Is Stalevo prescribed for all Parkinson’s patients?

Health Canada authorizes Stalevo for the treatment of Parkinson’s disease in adults experiencing motor fluctuations or “wearing off” despite standard levodopa/DDCI therapy.

The product is marketed as film-coated tablets in multiple strengths to match prior levodopa doses and is prescription-only.

Off-Label Uses By Canadian Physicians

Are there off-label scenarios where clinicians use Stalevo?

Some specialists may adjust regimens for complex motor fluctuations, but off-label use should be discussed, documented, and monitored for efficacy and safety.

Stalevo is not indicated for children under 18 years.

• Indication Confirmation Checklist: adult patient, wearing-off on levodopa/DDCI, prior therapy documented.
• When To Consult A Neurologist: persistent dyskinesia, psychosis, or complex motor fluctuations that do not respond to usual adjustments.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Wondering if diet or drinks will affect Stalevo?

Avoid binge drinking while taking Stalevo because alcohol can worsen dizziness and orthostatic hypotension.

Large protein meals can reduce levodopa absorption, so consider meal timing or lighter protein portions at main levodopa doses.

Caffeine may briefly improve alertness but can worsen dyskinesia in some patients, so discuss caffeine use with your clinician.

Drug Conflicts (Health Canada Database)

Which drugs interact with Stalevo?

Avoid non‑selective monoamine oxidase (MAO) inhibitors because of the risk of hypertensive crisis.

Monitor interactions with antihypertensives and psychotropic drugs due to increased risk of confusion, hallucinations, and orthostatic effects.

Entacapone may affect drugs cleared by hepatic pathways; always use the Health Canada Drug Product Database and consult your pharmacist for an up-to-date interaction check.

• High-Risk Drug Classes: non-selective MAO inhibitors, certain antipsychotics, some antihypertensives.
• Interaction-Check For Pharmacy Visits: bring all current medications, including OTCs and herbal products; confirm no MAO inhibitor overlap.

Latest Evidence & Insights

Canadian Studies And Clinical Experience

What do Canadian clinics report about adding entacapone?

Canadian neurologists and movement-disorder clinics commonly report that adding entacapone improves “on” time and reduces off-period disability in patients experiencing wearing-off while on levodopa/DDCI.

Observational Canadian series emphasize matching doses individually and close monitoring for dyskinesia and orthostatic symptoms.

International Trials And Guidelines

What do international trials show about Stalevo?

Randomized trials and regulatory summaries support that the levodopa/carbidopa/entacapone combination increases “on” time compared with levodopa/DDCI alone, with a known trade-off of increased dyskinesia risk in some patients.

The medication was approved by the FDA in 2003 and by the EMA in 2005, supporting its use for motor fluctuations.

Alternative Choices

Comparable Medicines

Wondering what alternatives exist to Stalevo?

Alternatives include levodopa/carbidopa combinations such as Sinemet, levodopa/benserazide (Madopar where available), and separate entacapone tablets (Comtan) that can be added to levodopa/DDCI therapy.

Advanced options include dopamine agonists, MAO‑B inhibitors, or infusion therapies; suitability depends on individual patient factors and specialist guidance.

Pros/Cons Checklist

• Pros: single-tablet convenience, fixed entacapone dose simplifies adherence, multiple strengths match prior levodopa regimens.
• Cons: less flexibility in entacapone titration, fixed levodopa increments may not suit every patient, potential cost and coverage barriers.

Regulation Snapshot

Health Canada Approval & DIN Requirements

Need to confirm product authenticity?

Stalevo is approved and marketed in Canada as a prescription-only film-coated tablet, and each marketed product has a Health Canada-assigned Drug Identification Number (DIN).

Always verify the DIN and expiry on the pack when you receive medication and report adverse events to Health Canada’s Canada Vigilance Program.

Provincial Reimbursement & Access

How does coverage differ across provinces?

Provincial coverage varies; many publicly funded plans require special authorization or criteria for entacapone-containing products.

Private plans also differ, so ask your pharmacist for prior-authorization support and about manufacturer patient-support programs when cost is a concern.

Plan refills early and coordinate timing with provincial formulary cycles if you live in a rural area.

FAQ Section

Common Patient Questions

Can Stalevo tablets be split?

Splitting is not recommended because of the film coating and the fixed 200 mg entacapone dose per tablet; consult your prescriber if you need a lower-strength option.

Why is my urine brown?

Entacapone can cause brownish urine; this is usually benign but report dark liver-coloured urine, jaundice, or other signs of liver dysfunction immediately.

What if I miss a dose?

Take a missed dose as soon as you remember but do not double the next dose; then resume your regular schedule.

When To Call Your Pharmacist/Doctor

Which symptoms are urgent?

Call your pharmacist for minor side effects, coverage, or refill issues.

Contact your prescriber or urgent care if you experience severe confusion, chest pain, fainting, severe dyskinesia, or signs of overdose.

• Red-Flag Symptoms: sudden severe confusion, loss of consciousness, chest pain, extreme uncontrolled involuntary movements.
• Quick Q&A: bring medication packaging and a list of other drugs when you call for an interaction check.

Guidelines For Proper Use

Canadian Pharmacist Recommendations

What should you bring to a pharmacy review?

Pharmacists recommend checking the tablet strength, confirming the DIN and bilingual information, and using a pillbox or blister calendar to track doses.

Bring all medications to medication reviews so interactions can be checked and adverse effects documented in provincial medication records.

Align refills with provincial coverage cycles and request pharmacist support for prior authorization paperwork if needed.

Provincial Health Authority Tips

How do provinces suggest planning refills and travel?

Provincial authorities stress prior authorization where required, early refill planning for remote patients, and documentation for work or travel accommodations.

Always transport medication in original packaging and carry a copy of your prescription and provincial health card when crossing provinces or borders.

• Pharmacy Visit Checklist: current prescription, medication list, provincial drug card, and recent symptom diary.
• Provincial Support Contacts: ask your local pharmacist for the correct phone numbers for provincial formulary help and prior-auth support.

Delivery Across Canada (English)

Closing Notes

Still have questions about starting or switching to Stalevo?

Bring a clear symptom diary, your current medication list, and tablet photos to your next prescriber or pharmacist appointment to speed up dose matching and coverage checks.

Remember that Stalevo is intended for adults with motor fluctuations on levodopa/DDCI therapy and should be used under medical supervision with regular follow-up.

Report any serious adverse events to Health Canada and discuss coverage or prior‑authorization steps with your pharmacy team when planning long-term refills.